Clear ×
Clene Inc. CLNN

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Oct 19, 2026 8-K 1 signal fired
Other
Form 8K Filing Disclosure
Oct 19, 2026 8-K 1 signal fired
Core
Indication Expansion
Sep 16, 2026 8-K 2 signals fired
Other
Ipo Net Proceeds Disclosure Use Of Proceeds Disclosure
Aug 14, 2026 10-Q 26 signals fired · top 15
Other
Financing Activities Cash Flow Disclosure Cash Flow Statement Investing Activities Warrant Valued Black Scholes Shares Outstanding Disclosure Ipo Net Proceeds Disclosure Publication Positive Expanded Access Program Active Net Loss Reported Interim Data Positive Pension Contribution Disclosure Convertible Debt Conversion Equity Plan Board Approval Conditional On Shareholder Vote Weighted Average Interest Rate Disclosed
Core
Clinical Trial Result
Biotech Risk
Clinical Hold Active
May 22, 2026 8-K 2 signals fired
Other
Equity Plan Board Approval Conditional On Shareholder Vote Form 8K Filing Disclosure
May 14, 2026 10-Q 25 signals fired · top 15
Other
Financing Activities Cash Flow Disclosure Ipo Net Proceeds Disclosure Shares Outstanding Disclosure Fast Track Granted Warrant Valued Black Scholes Orphan Status Granted Fast Track Designation Received Net Loss Reported Pension Contribution Disclosure Ipo Or Capital Raising Completion Equity Compensation Accounting Policy Debt Discount Amortization Disclosed Breakthrough Therapy Granted
Core
Regulatory Designation Only
Biotech Risk
Orphan Drug Designation
May 14, 2026 8-K 2 signals fired
Other
Form 8K Filing Disclosure Director Continuity Stated
May 5, 2026 8-K 2 signals fired
Other
Ipo Net Proceeds Disclosure Use Of Proceeds Disclosure
May 4, 2026 8-K 8 signals fired
Core
Regulatory Designation Only Indication Expansion
Other
Fast Track Granted Orphan Status Granted Fast Track Designation Received Breakthrough Therapy Granted Rmat Designation Received
Biotech Risk
Orphan Drug Designation